← Back to Clinical Trials
Recruiting NCT07224165

NCT07224165 Developing a Digital Intervention for Adolescent Nonsuicidal Self-injury

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07224165
Status Recruiting
Phase
Sponsor Northwestern University
Condition Nonsuicidal Self-injury
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2026-06-04
Primary Completion 2027-05-31

Eligibility & Interventions

Sex All sexes
Min Age 14 Years
Max Age 18 Years
Study Type INTERVENTIONAL
Interventions
App-based digital mental health intervention for adolescent NSSIApp-based delivery of healthy living psychoeducational materials

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 80 participants in total. It began in 2026-06-04 with a primary completion date of 2027-05-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This is a feasibility trial of a digital mental health intervention aimed at adolescents (ages 14-18) with nonsuicidal self-injury and who are not currently engaged in mental health treatment. The study has two arms: a self-guided DMHI and an active control which will involve the delivery of non-interactive psychoeducational content via the same app interface. The primary goals of this project are to evaluate the feasibility of the intervention and trial procedures in preparation for a fully-powered randomized-controlled trial.

Eligibility Criteria

Inclusion Criteria: * Current NSSI (NSSI on 2 or more days in the last month * English language skills sufficient to engage in the consent and intervention procedures * Age 14-18 * Access to smartphone Exclusion Criteria: * Severe mental health diagnoses for which this intervention would be inappropriate (psychotic disorders, active manic episodes) * Severe suicide risk, including suicidal ideation with a plan and intent to act * Current engagement in psychotherapy

Contact & Investigator

Central Contact

Kaylee Kruzan, PhD, LCSW

✉ kaylee.kruzan@northwestern.edu

📞 312-503-3114

Frequently Asked Questions

Who can join the NCT07224165 clinical trial?

This trial is open to participants of all sexes, aged 14 Years or older, up to 18 Years, studying Nonsuicidal Self-injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07224165 currently recruiting?

Yes, NCT07224165 is actively recruiting participants. Contact the research team at kaylee.kruzan@northwestern.edu for enrollment information.

Where is the NCT07224165 trial being conducted?

This trial is being conducted at Chicago, United States.

Who is sponsoring the NCT07224165 clinical trial?

NCT07224165 is sponsored by Northwestern University. The trial plans to enroll 80 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology